The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$2.44

Today's change-0.05 -2.01%
Updated February 5 4:24 PM EST. Delayed by at least 15 minutes.
 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$2.44

Today's change-0.05 -2.01%
Updated February 5 4:24 PM EST. Delayed by at least 15 minutes.

ProMetic Life Sciences Inc down $0.05

ProMetic Life Sciences Inc closed sharply lower Friday, dropping $0.05 or 2.01% to $2.44. Over the last five days, shares have lost 3.56% and are down 27.38% for the last year to date. This security has outperformed the S&P TSX by 44.03% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.06
Updated February 5 4:24 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-171.45%

Although this company's net profit margin is negative, it is above the industry average and implies that ProMetic Life Sciences Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Biotechnology

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue63211
Total other revenue--------
Total revenue63211
Gross profit4218
Total cost of revenue1112
Total operating expense17192012
Selling / general / administrative4435
Research & development12111012
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)046-7
Other operating expenses, total--------
Operating income-12-16-18-1
Interest income (expense), net non-operating-------1
Gain (loss) on sale of assets--------
Other--------
Income before tax-11-15-215
Income after tax-11-14-208
Income tax, total-1-1-1-4
Net income-9-12-199
Total adjustments to net income--------
Net income before extra. items-9-12-199
Minority interest1121
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-12-199
Inc. avail. to common incl. extra. items-9-12-199
Diluted net income-9-12-199
Dilution adjustment------0
Diluted weighted average shares581569552727
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.02-0.030.01
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.02-0.02-0.030.01